Check Cap Ltd

CHEK05 Dec 2024
Healthcare
$0.8
+0.03 (+2.74%)
Lowest Today
$0.8
Highest Today
$0.83
Today’s Open
$0.8
Prev. Close
$0.8
52 Week High
$3.45
52 Week Low
$0.76
To Invest in Check Cap Ltd

Check Cap Ltd

Healthcare
CHEK05 Dec 2024
+0.03 (+2.74%)
1M
3M
6M
1Y
5Y
Low
$0.8
Day’s Range
High
$0.83
0.8
52 Week Low
$0.76
52-Week Range
52 Week High
$3.45
0.76
1 Day
-
1 Week
-
1 month return
-28.18%
3 month return
-54.33%
6 month return
-64.41%
1 Year return
-70.95%
3 Years return
-94.42%
5 Years return
-97.11%
10 Years return
-
Institutional Holdings
DFA US Micro Cap I
0.15
UBS Group AG
0.07
Fidelity Nasdaq Composite Index
0.05
Morgan Stanley - Brokerage Accounts
0.03
Advisor Group Holdings, Inc.
0.03
JPMorgan Chase & Co
0.03
IFP Advisors, LLC
0.01

Market Status

Fundamentals
Market Cap
4.8 mln
PB Ratio
0.2
PE Ratio
0
Enterprise Value
-19.96 mln
Total Assets
25.02 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Organisation
Check Cap Ltd
Employees
0
Industry
Diagnostics & Research
CEO
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities